APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antidiabetic Sulphonylureas

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antidiabetic Sulphonylureas Industry Growth and Trends Forecast to 2032

Report ID 173966080120 December 2025107 pages

Choose your research edition.

Industry ResearchAntidiabetic Sulphonylureas Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiabetic Sulphonylureas Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antidiabetic Sulphonylureas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiabetic Sulphonylureas Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiabetic Sulphonylureas Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Antidiabetic Sulphonylureas market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiabetic Sulphonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antidiabetic Sulphonylureas include Boehringer Ingelheim, Bristol-Myers Squibb, Novo Nordisk, Servier Laboratories, AstraZeneca, GlaxoSmithKline, Pfizer, Eli Lilly and Merck & Co, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antidiabetic Sulphonylureas market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antidiabetic Sulphonylureas market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antidiabetic Sulphonylureas market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antidiabetic Sulphonylureas.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antidiabetic Sulphonylureas market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antidiabetic Sulphonylureas Market by Company

Boehringer Ingelheim

Bristol-Myers Squibb

Novo Nordisk

Servier Laboratories

AstraZeneca

GlaxoSmithKline

Pfizer

Eli Lilly

Merck & Co

Sanofi

Takeda Pharmaceuticals

Antidiabetic Sulphonylureas Segment by Type

First Generation Antidiabetic Sulphonylureas

The Second Generation Antidiabetic Sulphonylureas

The Third Generation Antidiabetic Sulphonylureas

Antidiabetic Sulphonylureas Segment by Application

Hospitals

Clinics

Other

Antidiabetic Sulphonylureas Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiabetic Sulphonylureas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiabetic Sulphonylureas and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiabetic Sulphonylureas.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antidiabetic Sulphonylureas manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antidiabetic Sulphonylureas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of First Generation Antidiabetic Sulphonylureas Table 2. Major Company of The Second Generation Antidiabetic Sulphonylureas Table 3. Major Company of The Third Generation Antidiabetic Sulphonylureas Table 4. Global Antidiabetic Sulphonylureas Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (K Units) Table 6. Global Antidiabetic Sulphonylureas Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antidiabetic Sulphonylureas Sales Market Share in Value by Type (2021-2026) Table 9. Global Antidiabetic Sulphonylureas Price by Type (2021-2026) & (US$/Unit) Table 10. Global Antidiabetic Sulphonylureas Sales by Type (2027-2032) & (K Units) Table 11. Global Antidiabetic Sulphonylureas Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antidiabetic Sulphonylureas Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antidiabetic Sulphonylureas Sales Market Share in Value by Type (2027-2032) Table 14. Global Antidiabetic Sulphonylureas Price by Type (2027-2032) & (US$/Unit) Table 15. North America Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (K Units) Table 16. North America Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (K Units) Table 18. Europe Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (K Units) Table 22. Latin America Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Antidiabetic Sulphonylureas Sales by Type (2021-2026) & (US$ Million) Table 25. Antidiabetic Sulphonylureas Industry Trends Table 26. Antidiabetic Sulphonylureas Industry Drivers Table 27. Antidiabetic Sulphonylureas Industry Opportunities and Challenges Table 28. Antidiabetic Sulphonylureas Industry Restraints Table 29. Global Antidiabetic Sulphonylureas Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antidiabetic Sulphonylureas Revenue Market Share by Company (2021-2026) Table 31. Global Antidiabetic Sulphonylureas Sales by Company (2021-2026) & (K Units) Table 32. Global Antidiabetic Sulphonylureas Sales Share by Company (2021-2026) Table 33. Global Antidiabetic Sulphonylureas Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Antidiabetic Sulphonylureas Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antidiabetic Sulphonylureas Major Company Production Sites and Headquarters Table 36. Global Antidiabetic Sulphonylureas Company, Product Type & Application Table 37. Global Antidiabetic Sulphonylureas Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antidiabetic Sulphonylureas by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antidiabetic Sulphonylureas Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antidiabetic Sulphonylureas Sales by Region (2021-2026) & (K Units) Table 42. Global Antidiabetic Sulphonylureas Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antidiabetic Sulphonylureas Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antidiabetic Sulphonylureas Sales Market Share in Value by Region (2021-2026) Table 45. Global Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Antidiabetic Sulphonylureas Sales by Region (2027-2032) & (K Units) Table 47. Global Antidiabetic Sulphonylureas Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antidiabetic Sulphonylureas Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antidiabetic Sulphonylureas Sales Market Share in Value by Region (2027-2032) Table 50. Global Antidiabetic Sulphonylureas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Antidiabetic Sulphonylureas Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (K Units) Table 53. Global Antidiabetic Sulphonylureas Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antidiabetic Sulphonylureas Sales Market Share in Value by Application (2021-2026) Table 56. Global Antidiabetic Sulphonylureas Price by Application (2021-2026) & (US$/Unit) Table 57. Global Antidiabetic Sulphonylureas Sales by Application (2027-2032) & (K Units) Table 58. Global Antidiabetic Sulphonylureas Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antidiabetic Sulphonylureas Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antidiabetic Sulphonylureas Sales Market Share in Value by Application (2027-2032) Table 61. Global Antidiabetic Sulphonylureas Price by Application (2027-2032) & (US$/Unit) Table 62. North America Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (K Units) Table 63. North America Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (K Units) Table 65. Europe Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (K Units) Table 69. Latin America Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Antidiabetic Sulphonylureas Sales by Application (2021-2026) & (US$ Million) Table 72. Boehringer Ingelheim Company Information Table 73. Boehringer Ingelheim Business Overview Table 74. Boehringer Ingelheim Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Boehringer Ingelheim Antidiabetic Sulphonylureas Product Portfolio Table 76. Boehringer Ingelheim Recent Development Table 77. Bristol-Myers Squibb Company Information Table 78. Bristol-Myers Squibb Business Overview Table 79. Bristol-Myers Squibb Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bristol-Myers Squibb Antidiabetic Sulphonylureas Product Portfolio Table 81. Bristol-Myers Squibb Recent Development Table 82. Novo Nordisk Company Information Table 83. Novo Nordisk Business Overview Table 84. Novo Nordisk Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Novo Nordisk Antidiabetic Sulphonylureas Product Portfolio Table 86. Novo Nordisk Recent Development Table 87. Servier Laboratories Company Information Table 88. Servier Laboratories Business Overview Table 89. Servier Laboratories Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Servier Laboratories Antidiabetic Sulphonylureas Product Portfolio Table 91. Servier Laboratories Recent Development Table 92. AstraZeneca Company Information Table 93. AstraZeneca Business Overview Table 94. AstraZeneca Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. AstraZeneca Antidiabetic Sulphonylureas Product Portfolio Table 96. AstraZeneca Recent Development Table 97. GlaxoSmithKline Company Information Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline Antidiabetic Sulphonylureas Product Portfolio Table 101. GlaxoSmithKline Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pfizer Antidiabetic Sulphonylureas Product Portfolio Table 106. Pfizer Recent Development Table 107. Eli Lilly Company Information Table 108. Eli Lilly Business Overview Table 109. Eli Lilly Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Eli Lilly Antidiabetic Sulphonylureas Product Portfolio Table 111. Eli Lilly Recent Development Table 112. Merck & Co Company Information Table 113. Merck & Co Business Overview Table 114. Merck & Co Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Merck & Co Antidiabetic Sulphonylureas Product Portfolio Table 116. Merck & Co Recent Development Table 117. Sanofi Company Information Table 118. Sanofi Business Overview Table 119. Sanofi Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Sanofi Antidiabetic Sulphonylureas Product Portfolio Table 121. Sanofi Recent Development Table 122. Takeda Pharmaceuticals Company Information Table 123. Takeda Pharmaceuticals Business Overview Table 124. Takeda Pharmaceuticals Antidiabetic Sulphonylureas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Takeda Pharmaceuticals Antidiabetic Sulphonylureas Product Portfolio Table 126. Takeda Pharmaceuticals Recent Development Table 127. North America Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 129. North America Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2026) Table 130. North America Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Antidiabetic Sulphonylureas Sales Market Share Forecast by Country (2027-2032) Table 132. North America Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Antidiabetic Sulphonylureas Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Antidiabetic Sulphonylureas Market Share by Country (2021-2026) Table 135. North America Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Antidiabetic Sulphonylureas Market Share Forecast by Country (2027-2032) Table 137. Europe Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 139. Europe Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2026) Table 140. Europe Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Antidiabetic Sulphonylureas Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Antidiabetic Sulphonylureas Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Antidiabetic Sulphonylureas Market Share by Country (2021-2026) Table 145. Europe Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Antidiabetic Sulphonylureas Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Antidiabetic Sulphonylureas Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Antidiabetic Sulphonylureas Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Antidiabetic Sulphonylureas Market Share by Country (2021-2026) Table 155. Asia-Pacific Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Antidiabetic Sulphonylureas Market Share Forecast by Country (2027-2032) Table 157. Latin America Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 159. Latin America Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2026) Table 160. Latin America Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Antidiabetic Sulphonylureas Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Antidiabetic Sulphonylureas Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Antidiabetic Sulphonylureas Market Share by Country (2021-2026) Table 165. Latin America Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Antidiabetic Sulphonylureas Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Antidiabetic Sulphonylureas Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Antidiabetic Sulphonylureas Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Antidiabetic Sulphonylureas Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Antidiabetic Sulphonylureas Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Antidiabetic Sulphonylureas Market Share by Country (2021-2026) Table 175. Middle East and Africa Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Antidiabetic Sulphonylureas Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Antidiabetic Sulphonylureas Distributors List Table 180. Antidiabetic Sulphonylureas Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Antidiabetic Sulphonylureas Image Figure 2. Global Antidiabetic Sulphonylureas Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiabetic Sulphonylureas Market Size (2021-2032) & (US$ Million) Figure 4. Global Antidiabetic Sulphonylureas Sales (2021-2032) & (K Units) Figure 5. First Generation Antidiabetic Sulphonylureas Image Figure 6. Global First Generation Antidiabetic Sulphonylureas Sales YoY Growth (2021-2032) & (K Units) Figure 7. The Second Generation Antidiabetic Sulphonylureas Image Figure 8. Global The Second Generation Antidiabetic Sulphonylureas Sales YoY Growth (2021-2032) & (K Units) Figure 9. The Third Generation Antidiabetic Sulphonylureas Image Figure 10. Global The Third Generation Antidiabetic Sulphonylureas Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Antidiabetic Sulphonylureas Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antidiabetic Sulphonylureas Market Share by Type 2025 VS 2032 Figure 13. North America Antidiabetic Sulphonylureas Sales Market Share in Volume by Type in 2025 Figure 14. North America Antidiabetic Sulphonylureas Sales Market Share in Value by Type in 2025 Figure 15. Europe Antidiabetic Sulphonylureas Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antidiabetic Sulphonylureas Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antidiabetic Sulphonylureas Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antidiabetic Sulphonylureas Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antidiabetic Sulphonylureas Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antidiabetic Sulphonylureas Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antidiabetic Sulphonylureas Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antidiabetic Sulphonylureas Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antidiabetic Sulphonylureas Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Antidiabetic Sulphonylureas Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antidiabetic Sulphonylureas Market Share by Application 2025 VS 2032 Figure 33. North America Antidiabetic Sulphonylureas Sales Market Share in Volume by Application in 2025 Figure 34. North America Antidiabetic Sulphonylureas Sales Market Share in Value by Application in 2025 Figure 35. Europe Antidiabetic Sulphonylureas Sales Market Share in Volume by Application in 2025 Figure 36. Europe Antidiabetic Sulphonylureas Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Antidiabetic Sulphonylureas Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Antidiabetic Sulphonylureas Sales Market Share in Value by Application in 2025 Figure 39. Latin America Antidiabetic Sulphonylureas Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Antidiabetic Sulphonylureas Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Antidiabetic Sulphonylureas Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Antidiabetic Sulphonylureas Sales Market Share in Value by Application in 2025 Figure 43. North America Antidiabetic Sulphonylureas Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Antidiabetic Sulphonylureas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Antidiabetic Sulphonylureas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Antidiabetic Sulphonylureas Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antidiabetic Sulphonylureas Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Antidiabetic Sulphonylureas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antidiabetic Sulphonylureas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Antidiabetic Sulphonylureas Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antidiabetic Sulphonylureas Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Antidiabetic Sulphonylureas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antidiabetic Sulphonylureas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Antidiabetic Sulphonylureas Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antidiabetic Sulphonylureas Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Antidiabetic Sulphonylureas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antidiabetic Sulphonylureas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Antidiabetic Sulphonylureas Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antidiabetic Sulphonylureas Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Antidiabetic Sulphonylureas Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antidiabetic Sulphonylureas Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Antidiabetic Sulphonylureas Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Antidiabetic Sulphonylureas Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Antidiabetic Sulphonylureas Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation Antidiabetic Sulphonylureas
  • The Second Generation Antidiabetic Sulphonylureas
  • The Third Generation Antidiabetic Sulphonylureas
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Novo Nordisk
  • Servier Laboratories
  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Merck & Co
  • Sanofi
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antidiabetic Sulphonylureas Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antidiabetic Sulphonylureas Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antidiabetic Sulphonylureas Market by Type
  6. 1.3.1 First Generation Antidiabetic Sulphonylureas
  7. 1.3.2 The Second Generation Antidiabetic Sulphonylureas
  8. 1.3.3 The Third Generation Antidiabetic Sulphonylureas
  9. 1.4 Global Antidiabetic Sulphonylureas Market Size by Type
  10. 1.4.1 Global Antidiabetic Sulphonylureas Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antidiabetic Sulphonylureas Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antidiabetic Sulphonylureas Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antidiabetic Sulphonylureas Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antidiabetic Sulphonylureas Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antidiabetic Sulphonylureas Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antidiabetic Sulphonylureas Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antidiabetic Sulphonylureas Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antidiabetic Sulphonylureas Industry Trends
  2. 2.2 Antidiabetic Sulphonylureas Industry Drivers
  3. 2.3 Antidiabetic Sulphonylureas Industry Opportunities and Challenges
  4. 2.4 Antidiabetic Sulphonylureas Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antidiabetic Sulphonylureas Revenue (2021-2026)
  2. 3.2 Global Top Players by Antidiabetic Sulphonylureas Sales (2021-2026)
  3. 3.3 Global Top Players by Antidiabetic Sulphonylureas Price (2021-2026)
  4. 3.4 Global Antidiabetic Sulphonylureas Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antidiabetic Sulphonylureas Major Company Production Sites & Headquarters
  6. 3.6 Global Antidiabetic Sulphonylureas Company, Product Type & Application
  7. 3.7 Global Antidiabetic Sulphonylureas Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antidiabetic Sulphonylureas Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antidiabetic Sulphonylureas Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antidiabetic Sulphonylureas Tier 1, Tier 2, and Tier 3
4 Antidiabetic Sulphonylureas Regional Status and Outlook
  1. 4.1 Global Antidiabetic Sulphonylureas Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antidiabetic Sulphonylureas Historic Market Size by Region
  3. 4.2.1 Global Antidiabetic Sulphonylureas Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antidiabetic Sulphonylureas Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antidiabetic Sulphonylureas Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antidiabetic Sulphonylureas Forecasted Market Size by Region
  7. 4.3.1 Global Antidiabetic Sulphonylureas Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antidiabetic Sulphonylureas Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antidiabetic Sulphonylureas Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antidiabetic Sulphonylureas by Application
  1. 5.1 Antidiabetic Sulphonylureas Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Antidiabetic Sulphonylureas Market Size by Application
  6. 5.2.1 Global Antidiabetic Sulphonylureas Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antidiabetic Sulphonylureas Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antidiabetic Sulphonylureas Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antidiabetic Sulphonylureas Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antidiabetic Sulphonylureas Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antidiabetic Sulphonylureas Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antidiabetic Sulphonylureas Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antidiabetic Sulphonylureas Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Antidiabetic Sulphonylureas Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Bristol-Myers Squibb
  8. 6.2.1 Bristol-Myers Squibb Company Information
  9. 6.2.2 Bristol-Myers Squibb Business Overview
  10. 6.2.3 Bristol-Myers Squibb Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb Antidiabetic Sulphonylureas Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Recent Developments
  13. 6.3 Novo Nordisk
  14. 6.3.1 Novo Nordisk Company Information
  15. 6.3.2 Novo Nordisk Business Overview
  16. 6.3.3 Novo Nordisk Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novo Nordisk Antidiabetic Sulphonylureas Product Portfolio
  18. 6.3.5 Novo Nordisk Recent Developments
  19. 6.4 Servier Laboratories
  20. 6.4.1 Servier Laboratories Company Information
  21. 6.4.2 Servier Laboratories Business Overview
  22. 6.4.3 Servier Laboratories Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Servier Laboratories Antidiabetic Sulphonylureas Product Portfolio
  24. 6.4.5 Servier Laboratories Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Antidiabetic Sulphonylureas Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GlaxoSmithKline Antidiabetic Sulphonylureas Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Antidiabetic Sulphonylureas Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly Antidiabetic Sulphonylureas Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 Merck & Co
  50. 6.9.1 Merck & Co Company Information
  51. 6.9.2 Merck & Co Business Overview
  52. 6.9.3 Merck & Co Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck & Co Antidiabetic Sulphonylureas Product Portfolio
  54. 6.9.5 Merck & Co Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Antidiabetic Sulphonylureas Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
  61. 6.11 Takeda Pharmaceuticals
  62. 6.11.1 Takeda Pharmaceuticals Company Information
  63. 6.11.2 Takeda Pharmaceuticals Business Overview
  64. 6.11.3 Takeda Pharmaceuticals Antidiabetic Sulphonylureas Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Takeda Pharmaceuticals Antidiabetic Sulphonylureas Product Portfolio
  66. 6.11.5 Takeda Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Antidiabetic Sulphonylureas Sales by Country
  2. 7.1.1 North America Antidiabetic Sulphonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antidiabetic Sulphonylureas Sales by Country (2021-2026)
  4. 7.1.3 North America Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antidiabetic Sulphonylureas Market Size by Country
  6. 7.2.1 North America Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antidiabetic Sulphonylureas Market Size by Country (2021-2026)
  8. 7.2.3 North America Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antidiabetic Sulphonylureas Sales by Country
  2. 8.1.1 Europe Antidiabetic Sulphonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antidiabetic Sulphonylureas Sales by Country (2021-2026)
  4. 8.1.3 Europe Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antidiabetic Sulphonylureas Market Size by Country
  6. 8.2.1 Europe Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antidiabetic Sulphonylureas Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antidiabetic Sulphonylureas Sales by Country
  2. 9.1.1 Asia-Pacific Antidiabetic Sulphonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antidiabetic Sulphonylureas Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antidiabetic Sulphonylureas Market Size by Country
  6. 9.2.1 Asia-Pacific Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antidiabetic Sulphonylureas Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antidiabetic Sulphonylureas Sales by Country
  2. 10.1.1 South America Antidiabetic Sulphonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antidiabetic Sulphonylureas Sales by Country (2021-2026)
  4. 10.1.3 South America Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antidiabetic Sulphonylureas Market Size by Country
  6. 10.2.1 South America Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antidiabetic Sulphonylureas Market Size by Country (2021-2026)
  8. 10.2.3 South America Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antidiabetic Sulphonylureas Sales by Country
  2. 11.1.1 Middle East and Africa Antidiabetic Sulphonylureas Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antidiabetic Sulphonylureas Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antidiabetic Sulphonylureas Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antidiabetic Sulphonylureas Market Size by Country
  6. 11.2.1 Middle East and Africa Antidiabetic Sulphonylureas Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antidiabetic Sulphonylureas Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antidiabetic Sulphonylureas Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antidiabetic Sulphonylureas Value Chain Analysis
  2. 12.1.1 Antidiabetic Sulphonylureas Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antidiabetic Sulphonylureas Production Mode & Process
  7. 12.2 Antidiabetic Sulphonylureas Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antidiabetic Sulphonylureas Distributors
  10. 12.2.3 Antidiabetic Sulphonylureas Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst